Replies to post #155035 on Verus International Inc (VRUS)

[Lil BD]

Nest he'd also have to file Form 4 immediately due to his % ownership if he changes his position. No Form 4, no buys or sells!
#VirusForTheWin

[price_and_volume]

Had a look at $CRON chart lately?

Maybe Garnock makes $$ but his shareholders suffer

[JOHNNY-VEGAS]

MANUFACTURING IS ANOTHER BIG LIE.


Been asking for the exact address of this fake manufacturing for months.

Why can't the company just provide?

And vrus will never hit a milestone, except in dreams and fantasies
..........................................

Below is the Q1 results folks.

As of April 20, 2020 OS 2,330,764,404 BILLION shares.

AS 7,500,000,000 BILLION shares .

revenue $6,173,662 for the three months ended January 31, 2020.

Cost of revenue totaled $5,040,105 for the three months ended January 31, 2020.

a net loss of $2,503,288 for the three months ended January 31, 2020, compared to a net loss of $338,489 for the three months ended January 31, 2019.

At January 31, 2020, we had $245,836 of cash and a working capital deficit of $610,342 .

an accumulated deficit of $30,997,878.

MAIN SOURCE OF INCOME, TOXIC NOTES.

On January 2, 2020, the Company entered into Amendment #1 to the convertible note dated July 1, 2019 in the principal amount of $605,000 (including a $90,000 original issuance discount), amending the conversion price. As a result of this amendment, the outstanding balance was determined extinguished and a loss on convertible note payable extinguishment of $355,317 was recognized, and a new liability was established. On various dates through January 31, 2020, the outstanding principal and accrued interest was converted into an aggregate of 81,623,171 shares of the Company’s common stock at an average conversion price of $0.009527, resulting in the recognition of a loss on convertible note payable settlement of $368,456. At January 31, 2020, 66,525,117 shares, valued at $465,675, are to be issued.